$1.79
-0.18 (-9.14%)
Open$2.04
Previous Close$1.97
Day High$2.07
Day Low$1.68
52W High$6.24
52W Low$1.41
Volume—
Avg Volume149.3K
Market Cap9.17M
P/E Ratio—
EPS$-2.77
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,338.0% upside
Current
$1.79
$1.79
Target
$43.64
$43.64
$27.68
$43.64 avg
$53.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.48M | 2.68M | 1.47M |
| Net Income | -9,986,831 | -6,934,764 | 533.2K |
| Profit Margin | -287.4% | -273.0% | 36.3% |
| EBITDA | -10,002,720 | -7,331,675 | 838.1K |
| Free Cash Flow | — | — | 521.2K |
| Rev Growth | +29.6% | +29.6% | +11.3% |
| Debt/Equity | 0.02 | 0.02 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |